BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29416644)

  • 1. C-MYC and BCL-2 mediate YAP-regulated tumorigenesis in OSCC.
    Chen X; Gu W; Wang Q; Fu X; Wang Y; Xu X; Wen Y
    Oncotarget; 2018 Jan; 9(1):668-679. PubMed ID: 29416644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin inhibits mTOR and c-Myc by decreasing YAP protein expression in OSCC cells.
    Wang Y; Zhang Y; Feng X; Tian H; Fu X; Gu W; Wen Y
    Oncol Rep; 2021 Mar; 45(3):1249-1260. PubMed ID: 33650651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yes-associated protein promotes cell migration via activating Wiskott-Aldrich syndrome protein family member 1 in oral squamous cell carcinoma.
    Qi L; Shi C; Li J; Xu S; Han Y; Li J; Zhang L
    J Oral Pathol Med; 2019 Apr; 48(4):290-298. PubMed ID: 30697796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yes-associated protein promotes cell proliferation by activating Fos Related Activator-1 in oral squamous cell carcinoma.
    Zhang L; Ye DX; Pan HY; Wei KJ; Wang LZ; Wang XD; Shen GF; Zhang ZY
    Oral Oncol; 2011 Aug; 47(8):693-7. PubMed ID: 21708480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis using ATN as a novel Yes-associated protein inhibitor in human oral squamous cell carcinoma cells.
    Chu PC; Dokla EME; Hu JL; Weng JR
    Environ Toxicol; 2022 Jun; 37(6):1404-1412. PubMed ID: 35212453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Yes-associated Protein in Oral Squamous Cell Carcinoma.
    Shelke P; Sarode GS; Sarode SC; Maniyar N; Prajapati G; Patil S
    J Contemp Dent Pract; 2019 Aug; 20(8):887-892. PubMed ID: 31797842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPR39 Overexpression in OSCC Promotes YAP-Sustained Malignant Progression.
    Jiang Y; Li T; Wu Y; Xu H; Xie C; Dong Y; Zhong L; Wang Z; Zhao H; Zhou Y; Li J; Ji N; Zeng X; Feng X; Chen Q
    J Dent Res; 2020 Jul; 99(8):949-958. PubMed ID: 32325008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/β-catenin signaling.
    Liang S; Zhang S; Wang P; Yang C; Shang C; Yang J; Wang J
    Gene; 2017 Apr; 608():49-57. PubMed ID: 28119088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressive effect of microRNA-126 on oral squamous cell carcinoma in vitro.
    Yang X; Wu H; Ling T
    Mol Med Rep; 2014 Jul; 10(1):125-30. PubMed ID: 24789258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C1QTNF6 promotes oral squamous cell carcinoma by enhancing proliferation and inhibiting apoptosis.
    Song X; Li L; Shi L; Liu X; Qu X; Wei F; Wang K
    Cancer Cell Int; 2021 Dec; 21(1):666. PubMed ID: 34906149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KLK4 silencing inhibits the growth of oral squamous cell carcinoma through Wnt/β-catenin signaling pathway.
    Cui Z; Cui Y; Yang S; Luo G; Wang Y; Lou Y; Sun X
    Cell Biol Int; 2017 Apr; 41(4):392-404. PubMed ID: 28150891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIB3 promotes oral squamous cell carcinoma cell proliferation by activating the AKT signaling pathway.
    Shen P; Zhang TY; Wang SY
    Exp Ther Med; 2021 Apr; 21(4):313. PubMed ID: 33717256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-1294 inhibited oral squamous cell carcinoma growth by targeting c-Myc.
    Wang Z; Yan J; Zou T; Gao H
    Oncol Lett; 2018 Aug; 16(2):2243-2250. PubMed ID: 30008925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentiviral vector-mediated siRNA knockdown of the YAP gene inhibits growth and induces apoptosis in the SGC7901 gastric cancer cell line.
    Zhou Z; Zhu JS; Xu ZP; Zhang Q
    Mol Med Rep; 2011; 4(6):1075-82. PubMed ID: 21805037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAD-dependent methylenetetrahydrofolate dehydrogenase inhibits oral squamous cell carcinoma cell proliferation and promotes apoptosis.
    Zhao L; Cheng Z; Lu Z; Jin J
    Transl Cancer Res; 2021 Mar; 10(3):1457-1469. PubMed ID: 35116471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced susceptibility to apoptosis of oral squamous cell carcinoma cells subjected to combined treatment with anticancer drugs and phosphatidylinositol 3-kinase inhibitors.
    Iwase M; Yoshiba S; Uchid M; Takaoka S; Kurihara Y; Ito D; Hatori M; Shintani S
    Int J Oncol; 2007 Nov; 31(5):1141-7. PubMed ID: 17912441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of YAP inhibits proliferation and induces apoptosis in Eca-109 cells.
    Cui M; Li Z
    Exp Ther Med; 2018 Jan; 15(1):1048-1052. PubMed ID: 29403552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HnRNP-L promotes prostate cancer progression by enhancing cell cycling and inhibiting apoptosis.
    Zhou X; Li Q; He J; Zhong L; Shu F; Xing R; Lv D; Lei B; Wan B; Yang Y; Wu H; Mao X; Zou Y
    Oncotarget; 2017 Mar; 8(12):19342-19353. PubMed ID: 28038443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between expression of Livin and the biological behavior of human oral squamous cell carcinoma.
    Lee DH; Yoon TM; Kim SA; Park YL; Lee KH; Lim SC; Lee JK; Joο YE
    Oncol Rep; 2014 Dec; 32(6):2453-60. PubMed ID: 25242075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes.
    Mizuno T; Murakami H; Fujii M; Ishiguro F; Tanaka I; Kondo Y; Akatsuka S; Toyokuni S; Yokoi K; Osada H; Sekido Y
    Oncogene; 2012 Dec; 31(49):5117-22. PubMed ID: 22286761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.